RY 171.32 -0.1632% SHOP 146.83 -1.1179% TD 77.94 -1.1792% ENB 60.14 0.8384% BN 79.29 0.8394% TRI 224.35 -0.6422% CNQ 47.02 -0.318% CP 102.7 -0.993% CNR 149.12 -1.8947% BMO 130.825 0.3798% BNS 78.15 0.9299% CSU 4473.1602 0.5369% CM 89.8 0.0892% MFC 45.39 0.1324% ATD 77.605 -0.9635% NGT 60.16 1.3306% TRP 69.13 -1.144% SU 57.07 -0.2273% WCN 262.59 0.7482% L 175.29 -1.5114%
Company Overview: Aurora Cannabis Inc. (TSX: ACB) is a Canada-based medical cannabis company that focuses on the production, distribution and sale of cannabis and cannabis derivative products in Canada and internationally. Numinus Wellness Inc. (TSX: NUMI) develops proprietary, psychedelic-centered, therapeutic products and services through its own laboratory and research & development processes. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Canada Market Round-Up
The benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week negatively and traded in a bearish zone. On June 22, 2023, the index closed at 600.87 with an overall week-to-date (WTD) loss of 2.11%. Consumer Cyclicals, and Technology were the leading sectors, while Real-Estate, Energy, Consumer Non-Cyclicals, Base Metals, Healthcare, and Industrials were the laggards on Thursday.
As per the weekly chart analysis, the index prices are trading below a horizontal trend line resistance zone. The leading indicator RSI (14-period) is hovering below the midpoint and is showing a reading of ~44.19. Furthermore, the prices are trading below the 21-period & 50-period SMAs, which may act as a dynamic resistance zone in the near term.
Global Markets Wrap-Up
On June 22, 2023, the S&P 500 index settled at 4381.89 with a WTD loss of 0.63%; moreover, the tech-heavy NASDAQ composite decreased by ~0.43% on a WTD basis and settled at 13630.61 while, Russell 2000 settled at 1848.18, reflecting a loss of ~1.45% on WTD basis.
Considering the US market's performance over the week, following the significant global macros and data front, and analyzing the S&P/TSX Venture Composite Index, two TSX-listed stocks fit the criteria on the technical framework: Aurora Cannabis Inc. (TSX: ACB) and Numinus Wellness Inc. (TSX: NUMI). The recommendations on these stocks are based on the generic insights, entry price, target prices, and stop-loss for the next 2-6 weeks:
Aurora Cannabis Inc. (TSX: ACB)
Noted below are the key price indicators for the stock:
Price Action Analysis (on the Daily Chart)
On the daily chart, ACB stock price is trading above the falling trendline support, indicating the possibility of an upside movement hereon. The next resistance level is plotted around CAD 0.93, and the price may test this level in the short term (2-6 weeks). A further movement above CAD 0.93 may extend buying in the stock.
Technical Analysis (On the Daily Chart)
On the weekly chart, the momentum oscillator RSI (14-Period) is showing a reading of ~59.22 levels, indicating positive momentum. The weekly volumes also seem supportive of an upside movement. Moreover, the current market price (CMP) is above the trend-following indicators 21-period & 50-period SMAs, which may act as the support levels.
General Recommendation:
As per the above-mentioned price action and technical indicators analysis, Aurora Cannabis Inc. is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. Investment decisions should be made depending on an individual's appetite for upside potential, risks, and any previous holdings. Aurora Cannabis Inc. (TSX: ACB) was last covered in a report dated ’19 May 2023. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report. The summary of recommendations is as follows:
Numinus Wellness Inc. (TSX: NUMI)
Noted below are the key price indicators for the stock:
Price Action Analysis (on the Daily Chart)
On the daily chart, NUMI stock price is trading above the downward sloping trendline support, indicating the possibility of an upside movement hereon. The next resistance level is plotted around CAD 0.295, and the price may test this level in the short term (2-6 weeks). A further movement above CAD 0.295 may extend buying in the stock.
Technical Analysis (On the Daily Chart)
On the weekly chart, the momentum oscillator RSI (14-Period) is showing a reading of ~66.71 levels, indicating positive momentum. The weekly volumes also seem supportive of an upside movement. Moreover, the current market price (CMP) is above the trend-following indicators 21-period & 50-period SMAs, which may act as the support levels.
General Recommendation:
As per the above-mentioned price action and technical indicators analysis, Numinus Wellness Inc. is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. Investment decisions should be made depending on an individual's appetite for upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report. The summary of recommendations is as follows:
Upcoming Major Global Economic Events
Market events occur daily depending on the data's frequency and generally include updates on CPI, PPI, Core Retail Sales, Unemployment Data, etc. The upcoming week's major global economic events that could impact the S&P/TSX Venture Composite Index and listed stocks' prices are noted below.
Related Risks: This report may be looked at from a high-risk perspective and recommendation is provided for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.
Note 1: Individuals can consider exiting from the stock if the Target Price or Stop loss mentioned as per the technical analysis has been achieved and subject to the factors discussed above.
Note 2: How to Read the Charts?
The Green color line reflects the 21-period moving average, while the red color line indicates the 50-period moving average. SMA helps to identify existing price trend. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.
The Black color line in the chart's lower segment reflects the Relative Strength Index (14-Period), which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status, while a reading of 30 or below suggests an oversold status.
The Blue color bars in the chart's lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume. Liquidity in stocks helps in easier and faster execution of the order.
The Orange color lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.
Technical Indicators Defined: -
Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.
Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.
Stop-loss: In general, it is a level to protect further losses in case of unfavorable movement in the stock prices.
Risk Reward Ratio: The risk reward ratio is the difference between an entry point to a stop loss and profit level and the report is based on ~60% Stop Loss of the Target 1 from the entry point.
A trailing stop-loss is a modification of stop-loss in case of favorable movement in the price to protect the gains. Individual can Trail the Stop-Loss as per the levels if the stock price achieves more than 50% of the Target 1. Individual should consider exiting from the position as per the Trailing Stop-Loss level if the price starts moving downwards after achieving more than 50% of the Target 1.
The reference date for all price data, currency, technical indicators, support, and resistance levels is June 22, 2023. The reference data in this report has been partly sourced from REFINITIV.
Abbreviations
CMP: Current Market Price
SMA: Simple Moving Average
CAD: Canadian Dollar
RSI: Relative Strength Index
Note: Trading decisions require a thorough analysis by individuals. Technical reports in general chart out metrics that may be assessed by individuals before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an indicator nor a guarantee of future performance.
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.